Global Crown Capital

Global Crown Capital was a San Francisco-based boutique investment bank and broker-dealer that operated from 2001 until its expulsion in 2011. The firm specialized in providing investment research, asset management, and corporate finance services, with a significant focus on emerging growth companies in the technology and healthcare sectors. During its years of operation, the firm frequently acted as a placement agent and financial advisor for various biotechnology and life science companies, assisting them with private placements and capital raising. However, the firm is primarily known for its regulatory downfall; it was expelled from the securities industry by FINRA in 2011 following allegations of fraud, unauthorized trading, and failure to maintain required records. As a financial services entity, Global Crown Capital did not engage in direct drug development and did not possess a therapeutic pipeline.